University Of Vermont
Clinical trials sponsored by University Of Vermont, explained in plain language.
-
Needle in a tumor: new approach aims to cut chemo side effects in lung cancer
Disease control Not yet recruitingThis early-phase study tests injecting the chemotherapy drug cisplatin directly into lung tumors using a thin tube with a camera, rather than giving it through a vein. The goal is to see if this method is safe and can kill cancer cells while causing fewer side effects. The study …
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Targeted chemo delivery could boost pancreatic cancer surgery success
Disease control Not yet recruitingThis early-stage trial tests whether delivering a standard chemotherapy drug (gemcitabine) directly to the tumor through a special catheter can improve outcomes for people with borderline resectable pancreatic cancer. Ten participants will receive standard chemo and radiation, fo…
Phase: PHASE1, PHASE2 • Sponsor: University of Vermont • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Remote exercise program aims to boost strength in 9/11 responders with prostate cancer
Symptom relief Not yet recruitingThis study tests whether a 16-week remote exercise program can improve physical function and quality of life in 40 World Trade Center responders who have had prostate cancer. Participants will exercise together via video calls three times a week. The goal is to see if the program…
Phase: NA • Sponsor: University of Vermont • Aim: Symptom relief
Last updated May 01, 2026 18:26 UTC